Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
(2001) In Blood 98(11). p.602-602
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/1118596
- author
 - Lindén, Ola LU ; Tennvall, F ; Cavallin-Ståhl, Eva LU ; Darte, Lennart LU ; Ohlsson, Tomas G LU ; Hindorf, Cecilia LU ; Wingårdh, Karin LU and Strand, Sven-Erik LU
 - organization
 - publishing date
 - 2001
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - in
 - Blood
 - volume
 - 98
 - issue
 - 11
 - pages
 - 602 - 602
 - publisher
 - American Society of Hematology
 - external identifiers
 - 
                
- wos:000172134102531
 
 - ISSN
 - 1528-0020
 - language
 - English
 - LU publication?
 - yes
 - id
 - 91742a47-6b56-462e-95a8-a56443459269 (old id 1118596)
 - date added to LUP
 - 2016-04-01 11:49:32
 - date last changed
 - 2025-04-04 14:21:47
 
@article{91742a47-6b56-462e-95a8-a56443459269,
  author       = {{Lindén, Ola and Tennvall, F and Cavallin-Ståhl, Eva and Darte, Lennart and Ohlsson, Tomas G and Hindorf, Cecilia and Wingårdh, Karin and Strand, Sven-Erik}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{602--602}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule}},
  volume       = {{98}},
  year         = {{2001}},
}